Vaxart, Inc.
VXRT· OTC
VXRTVaxart, Inc.
Filed Feb 11, 2013 · 10-Q · 42 days after period end · 0001437749-13-001370
| Metric | Q2 2013 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $10.40M | $3.74M | $4.85M |
| Net Income | $4.60M | -$4.60M | -$3.41M |
| EPS Diluted | $0.16 | -$0.11 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Feb 11, 2013 · 42 d after period end
